These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 19660721

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival.
    Kumar P, Defor TE, Brunstein C, Barker JN, Wagner JE, Weisdorf DJ, Burns LJ.
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1394-400. PubMed ID: 19041062
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B-Cell acute lymphoblastic leukemia.
    Segal E, Martens M, Wang HL, Brazauskas R, Weisdorf D, Sandmaier BM, Khoury HJ, de Lima M, Saber W.
    Cancer; 2017 Sep 01; 123(17):3346-3355. PubMed ID: 28452054
    [Abstract] [Full Text] [Related]

  • 7. Similar outcomes of allogeneic hematopoietic cell transplantation from unrelated donor and umbilical cord blood vs. sibling donor for pediatric acute myeloid leukemia: Multicenter experience in China.
    Tang X, Chen J, Fang J, Sun X, Qin MQ, Li J, Zhu Y, Luan Z.
    Pediatr Transplant; 2015 Jun 01; 19(4):413-21. PubMed ID: 25903451
    [Abstract] [Full Text] [Related]

  • 8. Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse.
    Weisdorf DJ, Nelson G, Lee SJ, Haagenson M, Spellman S, Antin JH, Bolwell B, Cahn JY, Cervantes F, Copelan E, Gale R, Gratwohl A, Khoury HJ, McCarthy P, Marks DI, Szer J, Woolfrey A, Cortes-Franco J, Horowitz MM, Arora M, Chronic Leukemia Working Committee.
    Biol Blood Marrow Transplant; 2009 Nov 01; 15(11):1475-8. PubMed ID: 19822308
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.
    Lazaryan A, Weisdorf DJ, DeFor T, Brunstein CG, MacMillan ML, Bejanyan N, Holtan S, Blazar BR, Wagner JE, Arora M.
    Biol Blood Marrow Transplant; 2016 Jan 01; 22(1):134-40. PubMed ID: 26365153
    [Abstract] [Full Text] [Related]

  • 11. Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia.
    Zhang MJ, Davies SM, Camitta BM, Logan B, Tiedemann K, Eapen M, Thiel EL.
    Biol Blood Marrow Transplant; 2012 Aug 01; 18(8):1204-10. PubMed ID: 22406037
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China.
    Liu QF, Xu XJ, Chen YK, Sun J, Zhang Y, Fan ZP, Xu D, Jiang QL, Wei YQ, Huang F, Feng R, Liu XL, Xu B, Meng FY.
    Ann Hematol; 2011 Mar 01; 90(3):331-41. PubMed ID: 20872002
    [Abstract] [Full Text] [Related]

  • 13. Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia from a Matched Donor versus an HLA-Identical Sibling: Is the Outcome Comparable? Results from the International BFM ALL SCT 2007 Study.
    Balduzzi A, Dalle JH, Wachowiak J, Yaniv I, Yesilipek A, Sedlacek P, Bierings M, Ifversen M, Sufliarska S, Kalwak K, Lankester A, Toporski J, Di Maio L, Glogova E, Poetschger U, Peters C.
    Biol Blood Marrow Transplant; 2019 Nov 01; 25(11):2197-2210. PubMed ID: 31319153
    [Abstract] [Full Text] [Related]

  • 14. Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for international blood and marrow transplant research-eurocord analysis.
    Weisdorf D, Eapen M, Ruggeri A, Zhang MJ, Zhong X, Brunstein C, Ustun C, Rocha V, Gluckman E.
    Biol Blood Marrow Transplant; 2014 Jun 01; 20(6):816-22. PubMed ID: 24582782
    [Abstract] [Full Text] [Related]

  • 15. Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission.
    Konuma T, Kanda J, Yamasaki S, Harada K, Shimomura Y, Terakura S, Mizuno S, Uchida N, Tanaka M, Doki N, Ozawa Y, Nakamae H, Sawa M, Matsuoka KI, Morishige S, Maruyama Y, Ikegame K, Kimura T, Kanda Y, Ichinohe T, Atsuta Y, Yanada M.
    Transplant Cell Ther; 2021 Apr 01; 27(4):334.e1-334.e11. PubMed ID: 33836881
    [Abstract] [Full Text] [Related]

  • 16. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.
    Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W, Sirvent A, Champlin RE, Chao N, Gee AP, Isola L, Laughlin MJ, Marks DI, Nabhan S, Ruggeri A, Soiffer R, Horowitz MM, Gluckman E, Wagner JE, Center for International Blood and Marrow Transplant Research, Acute Leukemia Working Party Eurocord (the European Group for Blood Marrow Transplantation), National Cord Blood Program of the New York Blood Center.
    Lancet Oncol; 2010 Jul 01; 11(7):653-60. PubMed ID: 20558104
    [Abstract] [Full Text] [Related]

  • 17. Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: comparison among alternative graft sources.
    Ballen KK, Joffe S, Brazauskas R, Wang Z, Aljurf MD, Akpek G, Dandoy C, Frangoul HA, Freytes CO, Khera N, Lazarus HM, LeMaistre CF, Mehta P, Parsons SK, Szwajcer D, Ustun C, Wood WA, Majhail NS.
    Biol Blood Marrow Transplant; 2014 Nov 01; 20(11):1819-27. PubMed ID: 25064747
    [Abstract] [Full Text] [Related]

  • 18. Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants.
    Kumar AJ, Kim S, Hemmer MT, Arora M, Spellman SR, Pidala JA, Couriel DR, Alousi AM, Aljurf MD, Cahn JY, Cairo MS, Cutler CS, Farhan S, Gergis U, Hale GA, Hashmi SK, Inamoto Y, Kamble RT, Kharfan-Dabaja MA, MacMillan ML, Marks DI, Nakasone H, Norkin M, Qayed M, Ringden O, Schouten HC, Schultz KR, Solh MM, Teshima T, Urbano-Ispizua A, Verdonck LF, Gale RP, Hamilton BK, Majhail NS, Loren AW.
    Blood Adv; 2018 May 08; 2(9):1022-1031. PubMed ID: 29739773
    [Abstract] [Full Text] [Related]

  • 19. The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.
    Ringdén O, Pavletic SZ, Anasetti C, Barrett AJ, Wang T, Wang D, Antin JH, Di Bartolomeo P, Bolwell BJ, Bredeson C, Cairo MS, Gale RP, Gupta V, Hahn T, Hale GA, Halter J, Jagasia M, Litzow MR, Locatelli F, Marks DI, McCarthy PL, Cowan MJ, Petersdorf EW, Russell JA, Schiller GJ, Schouten H, Spellman S, Verdonck LF, Wingard JR, Horowitz MM, Arora M.
    Blood; 2009 Mar 26; 113(13):3110-8. PubMed ID: 19059878
    [Abstract] [Full Text] [Related]

  • 20. No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission.
    Saarinen-Pihkala UM, Gustafsson G, Ringdén O, Heilmann C, Glomstein A, Lönnerholm G, Abrahamsson J, Bekassy AN, Schroeder H, Mellander L, Nordic Society of Pediatric Hematology and Oncology.
    J Clin Oncol; 2001 Jul 15; 19(14):3406-14. PubMed ID: 11454889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.